Summary
Boston Scientific Corporation (BSX) filed an 8-K on February 4, 2014, primarily to report its financial results for the fourth quarter and full year ended December 31, 2013. The report itself is brief, as the core financial details and operational performance are contained within the accompanying press release (Exhibit 99.1), which is furnished with the filing. Investors should refer to this press release for comprehensive information regarding the company's financial condition and results of operations for the reported periods. This filing serves as the official notification of the release of these results, indicating that the company has met its disclosure obligations regarding quarterly and annual performance. While the 8-K itself does not provide the detailed figures, it directs investors to the source document where these critical metrics, such as revenue, profitability, and any forward-looking statements, can be found. The information is furnished, not filed, meaning it does not carry the same legal implications as a formally filed document under Section 18 of the Exchange Act.
Key Highlights
- 1Boston Scientific Corporation announced its financial results for Q4 and full year 2013 via a press release on February 4, 2014.
- 2The 8-K filing serves as the official notification of the earnings release.
- 3The detailed financial results are provided in an attached press release (Exhibit 99.1).
- 4Investors should consult Exhibit 99.1 for specific figures on revenue, profit, and other financial metrics.
- 5The information furnished in this 8-K is not deemed 'filed' under Section 18 of the Exchange Act.
- 6This filing marks the company's public disclosure of its 2013 year-end and Q4 performance.